Physician profile
Matthew Burstein
NPI 1386031839
$46,930.77
in general payments reported to CMS, 2019-2025
28 companies · $15K in 2025
The $15K reported for 2025 was more than what 96% of Surgery providers received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,572 · 2020: $125 · 2021: $198 · 2022: $1,816 · 2023: $5,469 · 2024: $21K · 2025: $15K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Education: $34K · Food and Beverage: $5,424 · Travel and Lodging: $2,779 · Gift: $16.25.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Education | $34,000.00 |
| Food and Beverage | $5,423.97 |
| Travel and Lodging | $2,779.33 |
| Gift | $16.25 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $40,433.05 | 2019-2025 | Da Vinci Surgical System |
| W. L. Gore & Associates, INC. | $3,111.94 | 2023-2025 | Gore Bio-A Tissue Reinforcement, Seamguard, Gore Synecor Biomaterial |
| Medical Device Business Services, INC. | $1,119.39 | 2022-2023 | Echelon Circular |
| Ethicon US, LLC | $199.93 | 2019-2022 | |
| Boston Scientific Corporation | $188.86 | 2022-2024 | Spyglass Discover |
| Integra Lifesciences Corporation | $185.95 | 2024 | Integra, Integra Dermal Regeneration Template, Primatrix |
| Tela Bio, INC. | $167.94 | 2022 | |
| Conmed Corporation | $158.00 | 2021-2024 | Airseal |
| Kerecis Limited | $143.98 | 2023 | Kerecis Omega3 Surgiclose, Kerecis Omega3 Marigen, Kerecis Omega3 Graftguide |
| Polynovo North America LLC | $142.23 | 2022 | |
| Qol Medical, LLC | $125.58 | 2023-2025 | Sucraid, Sucraid |
| Novo Nordisk INC | $125.00 | 2020 | |
| La Jolla Pharmaceutical Company | $123.34 | 2023 | Xerava |
| Regeneron Healthcare Solutions, INC. | $116.90 | 2023-2025 | Dupixent |
| Abbvie INC. | $112.23 | 2021-2022 |
Show all 28 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Davol INC. | $109.03 | 2019 | |
| Takeda Pharmaceuticals U.S.A., INC. | $69.00 | 2023-2025 | Entyvio |
| Lilly USA, LLC | $64.47 | 2024-2025 | Omvoh |
| Medtronic, INC. | $57.11 | 2023-2025 | Eea, V-Loc 180, Ligasure |
| Genzyme Corporation | $29.24 | 2023 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $24.50 | 2024 | Xifaxan |
| Nestle Healthcare Nutrition INC. | $24.15 | 2023 | |
| Aimmune Therapeutics, INC. | $23.16 | 2024 | |
| Pfizer INC. | $16.59 | 2019 | |
| Baxter Healthcare | $16.56 | 2023 | Floseal |
| Evoke Pharma, INC. | $15.60 | 2023 | Gimoti |
| Celltrion USA INC. | $13.57 | 2025 | Vegzelma |
| Braintree Laboratories, INC. | $13.47 | 2023 | Suflave |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Matthew Burstein listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.